Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Cash Flow-to-Debt Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥1.25 Billion could theoretically repay 0% of its total liabilities (CN¥8.77 Billion) in one year. Explore how much of Starlake Bioscience Co Inc Zhaoqing Guan's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. Also explore Starlake Bioscience Co Inc Zhaoqing Guan total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year debt coverage analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. For market capitalisation and broader financial context, see 600866 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -60.0% |
| 2024 | 0.37x | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +22.1% |
| 2023 | 0.30x | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +64.3% |
| 2022 | 0.18x | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -33.6% |
| 2021 | 0.28x | CN¥192.63 Million | CN¥697.74 Million | ▼ -16.8% |
| 2020 | 0.33x | CN¥249.99 Million | CN¥752.97 Million | ▼ -7.2% |
| 2019 | 0.36x | CN¥213.17 Million | CN¥595.95 Million | ▲ +245.0% |
| 2018 | 0.10x | CN¥50.69 Million | CN¥488.94 Million | ▲ +38.4% |
| 2017 | 0.07x | CN¥40.05 Million | CN¥534.57 Million | ▲ +16.1% |
| 2016 | 0.06x | CN¥41.17 Million | CN¥637.90 Million | ▲ +1771.0% |
| 2015 | 0.00x | CN¥2.75 Million | CN¥795.88 Million | ▲ +113.4% |
| 2014 | -0.03x | CN¥-20.22 Million | CN¥787.37 Million | ▼ -3.8% |
| 2013 | -0.02x | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +84.8% |
| 2012 | -0.16x | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -499.7% |
| 2011 | 0.04x | CN¥65.88 Million | CN¥1.62 Billion | ▼ -72.9% |
| 2010 | 0.15x | CN¥104.63 Million | CN¥698.07 Million | ▼ -77.4% |
| 2009 | 0.66x | CN¥316.73 Million | CN¥477.36 Million | ▲ +158.6% |
| 2008 | 0.26x | CN¥148.93 Million | CN¥580.44 Million | ▲ +89.4% |
| 2007 | 0.14x | CN¥82.28 Million | CN¥607.29 Million | ▲ +99.3% |
| 2006 | 0.07x | CN¥35.14 Million | CN¥516.89 Million | ▼ -28.9% |
| 2005 | 0.10x | CN¥46.83 Million | CN¥489.57 Million | ▲ +35.3% |
| 2004 | 0.07x | CN¥29.05 Million | CN¥410.86 Million | ▼ -87.4% |
| 2003 | 0.56x | CN¥149.70 Million | CN¥266.82 Million | ▼ -42.1% |
| 2002 | 0.97x | CN¥183.18 Million | CN¥188.89 Million | ▲ +292.2% |
| 2001 | 0.25x | CN¥60.82 Million | CN¥245.97 Million | ▼ -12.2% |
| 2000 | 0.28x | CN¥93.41 Million | CN¥331.53 Million | ▼ -23.5% |
| 1999 | 0.37x | CN¥52.97 Million | CN¥143.87 Million | ▼ -14.3% |
| 1998 | 0.43x | CN¥71.14 Million | CN¥165.54 Million | — |